CoChat

Do Atypical Antipsychotics Effectively Treat Co-Occurring Bipolar Disorder and Stimulant Dependence?: A Randomized, Double-Blind Trial

The DOI matches its Crossref record.

Abstract

OBJECTIVES: The primary objective was to compare the efficacy and tolerability of quetiapine and risperidone in the treatment of mood symptoms, drug cravings, and drug use in outpatients with concurrent DSM-IV-defined bipolar I or II disorder and cocaine or methamphetamine dependence. METHOD: Men and women of all ethnic origins, 20 to 50 years of age, were eligible to participate. Persons were excluded if they were inpatients, met DSM-IV criteria for substance-induced mood disorder, had any other substance dependence, were euthymic or suicidal, had any life-threatening illnesses, or were currently receiving antipsychotic medications. Duration of the trial was 20 weeks. Study participants attended weekly visits and were evaluated for mood symptoms, drug cravings, drug use, and medication side effects. Treatment outcomes were analyzed using linear mixed models. Fixed-effects terms for medication group, study week, and group-by-study-week were included in the models. The study was conducted between October 2002 and November 2006. RESULTS: Of 124 consenting outpatients, an evaluable sample of 80 patients who attended baseline and at least 1 follow-up study visit was formed. The mean +/- SD exit dose for quetiapine was 303.6 +/- 151.9 mg/day and 3.1 +/- 1.2 mg/day for risperidone. Both quetiapine (N = 42) and risperidone (N = 38) significantly improved manic and depressive symptoms and reduced drug cravings (p < .0005) compared to baseline. Decreased drug cravings were related to less frequent drug use (p = .03). The 2 medications did not significantly differ in their effects on mood symptoms, drug craving, or drug use. CONCLUSIONS: Relative to baseline mood and drug-craving status, both quetiapine and risperidone were associated with manic, mixed, and depressive symptom improvement and reduced drug cravings. Both medications were well tolerated. The interpretation of these results is limited by the absence of a placebo control. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00227123.

Overview

Integrity signals

Registry

Crossref · 10.4088/jcp.v69n0808

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cited by

See all 69

Metadata

Authors
Nejtek, V. A., Avila, M., Chen, L.-A., Zielinski, T., Djokovic, M., Podawlitz, A., Kaiser, K., Bae, S., & Rush, A. J.
Affiliations
  • University of North Texas Health Science Center (US)
  • University of North Texas (US)
  • The University of Texas Southwestern Medical Center (US)
Venue
The Journal of Clinical Psychiatry
Published
2008-08-15
Volume
69
Issue
8
Pages
1257-1266
ISSN
0160-6689 (ISSN-L)
OpenAlex
W2048029383
Cited by
69
References
0
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 4 · 2017: 5 · 2016: 6 · 2015: 4 · 2014: 9 · 2013: 7 · 2012: 9
FWCI
3.05
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
bipolar disorder, cocaine dependence, methamphetamine dependence, quetiapine, risperidone, atypical antipsychotics, drug craving, substance use, manic symptoms, depressive symptoms, mood stabilizers, outpatients, tolerability
MeSH terms
Quetiapine Fumarate, Adult, Bipolar Disorder, Demography, Dibenzothiazepines, Double-Blind Method, Electrocardiography, Female, Humans, Male, Methamphetamine, Middle Aged, Antipsychotic Agents, Comorbidity, Risperidone, Amphetamine-Related Disorders, Cocaine-Related Disorders, Diagnostic and Statistical Manual of Mental Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Do Atypical Antipsychotics Effectively Treat Co-Occurring Bipolar Disorder and Stimulant Dependence?: A Randomized, Double-Blind Trial. https://app.cochat.ai/papers/10.4088/jcp.v69n0808
The paper
Nejtek, V. A., Avila, M., Chen, L.-A., Zielinski, T., Djokovic, M., Podawlitz, A., Kaiser, K., Bae, S., & Rush, A. J. (2008). Do Atypical Antipsychotics Effectively Treat Co-Occurring Bipolar Disorder and Stimulant Dependence?: A Randomized, Double-Blind Trial. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v69n0808

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.